1. Gillani S, Cao J, Suzuki T, Hak DJ. The effect of ischemia reperfusion injury on skeletal muscle. Injury. 2012; 43:670–5.
Article
2. Kaszaki J, Wolfárd A, Szalay L, Boros M. Pathophysiology of ischemia-reperfusion Injury. Transplant Proc. 2006; 38:826–8.
Article
3. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012; 298:229–317.
Article
4. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol. 1988; 255:H1269–75.
Article
5. Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010; 10:826–37.
Article
6. Zhang F, Hu EC, Gerzenshtein J, Lei MP, Lineaweaver WC. The expression of proinflammatory cytokines in the rat muscle flap with ischemia-reperfusion injury. Ann Plast Surg. 2005; 54:313–7.
7. Zhang F, Hu EC, Topp S, Lei M, Chen W, Lineaweaver WC. Proinflammatory cytokines gene expression in skin flaps with arterial and venous ischemia in rats. J Reconstr Microsurg. 2006; 22:641–7.
Article
8. Dinarello CA. Proinflammatory cytokines. Chest. 2000; 118:503–8.
Article
9. Koh H-J. Joo J, Cho M-L, Her Y-M, Hwang J-E, Lee J. Proinflammatory and antiinflammatory cytokine balance in patients with cirrhotic hepatitis during live-donor liver transplant. Exp Clin Transplant. 2013; 11:39–43.
10. Lange M, Nakano Y, Traber DL, Hamahata A, Traber LD, Enkhbaatar P. Time course of the inflammatory and oxidative stress response to pulmonary infection in mice. Exp Lung Res. 2012; 38:157–63.
Article
11. Ohtsuka M, Takano H, Zou Y, Toko H, Akazawa H, Qin Y, et al. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J. 2004; 18:851–3.
Article
12. Gravante G, Ong S, Metcalfe M, Sorge R, Sconocchia G, Orlando G, et al. Cytokine response to ischemia/reperfusion injury in an ex vivo perfused porcine liver model. Transplant Proc. 2009; 41:1107–12.
Article
13. Yassin MM, Harkin DW, Barros D'Sa AA, Halliday MI, Rowlands BJ. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002; 26:115–21.
14. Krishnadasan B, Naidu BV, Byrne K, Fraga C, Verrier ED, Mulligan MS. The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2003; 125:261–72.
Article
15. Zhang Z, Pan C, Wang HZ, Li YX. Protective effects of osthole on intestinal ischemia-reperfusion injury in mice. Exp Clin Transplant. 2014; 12:246–52.
16. Serrick C, La Franchesca S, Giaid A, Shennib H. Cytokine interleukin-2, tumor necrosis factor-alpha, and interferon-gamma release after ischemia/reperfusion injury in a novel lung autograft animal model. Am J Respir Crit Care Med. 1995; 152:277–82.
Article
17. Auclair S, Roth K, Saunders B, Ogborn K, Sheikh A, Naples J, et al. Interleukin-3-deficient mice have increased resistance to blood-stage malaria. Infect Immun. 2014; 192:1308–14.
Article
18. Kamenetz Y, Beloosesky Y, Zeltzer C, Gotlieb D, Magaza-nik A, Fishman P, et al. Relationship between routine hematological parameters, serum IL-3, IL-6 and erythropoietin and mild anemia and degree of function in the elderly. Aging (Milano). 1998; 10:32–8.
Article
19. Meldrum DR, Ayala A, Perrin MM, Ertel W, Chaudry IH. Diltiazem restores IL-2, IL-3, IL-6, and IFN-γ synthesis and decreases host susceptibility to sepsis following hemorrhage. J Surg Res. 1991; 51:158–64.
Article
20. Xu YX, Wichmann MW, Ayala A, Cioffi WG, Chaudry IH. Trauma-hemorrhage induces increased thymic apoptosis while decreasing IL-3 release and increasing GM-CSF. J Surg Res. 1997; 68:24–30.
Article
21. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood. 1992; 79:3101–9.
Article
22. Li S, Zhu FX, Zhang HB, Li H, An YZ. Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice. Chin Med J (Engl). 2013; 126:1855–9.
23. Clementsen T, Reikeras O. Cytokine patterns after tourniquet-induced skeletal muscle ischaemia reperfusion in total knee replacement. Scand J Clin Lab Invest. 2008; 68:154–9.
Article
24. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol. 1993; 143:453–63.
25. Roy S, Das S, Munshi A, Kaul S, Jyothy A. Association of −1382A>G CCL11 gene variant with ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population. Neurol India. 2014; 62:387–92.
26. Nishi T, Maier CM, Hayashi T, Saito A, Chan PH. Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2005; 25:1312–24.
27. Ramos CD, Canetti C, Souto JT, Silva JS, Hogaboam CM, Ferreira SH, et al. MIP-1alpha [CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J Leukoc Biol. 2005; 78:167–77.
28. Naidu BV, Farivar AS, Woolley SM, Grainger D, Verrier ED, Mulligan MS. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant. 2004; 23:128–34.
Article
29. Richter JR, Sutton JM, Belizaire RM, Friend LA, Schuster RM, Johannigman TA, et al. Macrophage-derived chemokine (CCL22) is a novel mediator of lung inflammation following hemorrhage and resuscitation. Shock. 2014; 42:525–31.
Article
30. Marques RE, Guabiraba R, Russo RC, Teixeira MM. Targeting CCL5 in inflammation. Expert Opin Ther Targets. 2013; 17:1439–60.
Article
31. Levy JA. The unexpected pleiotropic activities of RANTES. J Immunol. 2009; 182:3945–6.
Article
32. Ritter M, Goggel R, Chaudhary N, Wiedenmann A, Jung B, Weith A, et al. Elevated expression of TARC (CCL17) and MDC (CCL22) in models of cigarette smoke-induced pulmonary inflammation. Biochem Biophys Res Commun. 2005; 334:254–62.
Article
33. Greaves DR, Häkkinen T, Lucas AD, Liddiard K, Jones E, Quinn CM, et al. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus and activation-regulated chemokine are expressed in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001; 21:923–9.
Article
34. Burne MJ, Daniels F, EI Ghandour A, Mauiyyedi S, Colvin RB, O'Donnell MP, et al. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest. 2001; 108:1283–90.
35. Daemen MA, van't Veer C, Wolfs TG, Buurman WA. Ischemia/reperfusion-induced IFN-gamma upregulation: involvement of IL-12 and IL-18. J Immunol. 1999; 162:5506–10.
36. Sukhotnik I, Miselevich I, Lurie M, Nativ O, Coran AG, Mogilner JG. The time relationship between ipsilateral testicular ischemia and germ cell apoptosis in the contralateral testis in rat. Pediatr Surg Int. 2005; 21:512–6.
Article